000020.KO Dongwha Pharm.Co.Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
5,190 KRW
Close of Nov 5, 2026
4,450 7,560
Market cap
KRW 144B
P/E
8.0x
P/B
0.37x
ROE
8.4%
Dividend yield
3.47%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 000020.KO undervalued?

Graham number
Price5,190
Graham value14,403
Discount64.0%

000020.KO trades 64.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dongwha Pharm.Co.Ltd fundamental analysis

No fundamental analysis for Dongwha Pharm.Co.Ltd yet.

Dongwha Pharm.Co.Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dongwha Pharm.Co.Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic ana…

Full company profile